WebDoctor Encyclopedia

Article

Lobectomy for Lung Cancer

What is a lobectomy?

A lobectomy is an operation to remove one lobe of a lung. It is the most common operation for early-stage lung cancer and offers one of the best chances of cure when the cancer has not spread.

The lungs are divided into sections called lobes. The right lung has three lobes (upper, middle and lower) and the left lung has two (upper and lower). Each lobe has its own airway, artery and veins. Because the cancer often spreads first within the lobe and to the lymph nodes that drain it, removing the whole lobe with its lymph nodes is a reliable way of taking away the tumour and the tissue around it.

People can live a full life with one lobe missing. The remaining lung expands to fill some of the space, and most people return to their usual activities, although very strenuous exercise may feel harder than before.

Lobectomy can be done through a larger cut between the ribs (open surgery, or thoracotomy) or, more often today, through several small cuts using a camera, called video-assisted thoracoscopic surgery (VATS), or with a surgical robot.

A brief history

The first successful removal of a whole lung for cancer was performed by Evarts Graham in 1933. Over the following decades, surgeons found that removing just the affected lobe was usually enough and preserved more breathing capacity. In 1995, a North American trial confirmed lobectomy as the standard operation for small lung cancers (Ginsberg and Rubinstein, 1995). Keyhole lobectomy spread from the 1990s onwards, and recent trials have reopened the question of whether smaller operations are enough for very small tumours.

1. Key facts at a glance

Feature Details
Type of treatment Surgery
Main use Early-stage non-small cell lung cancer
What is removed One lobe of the lung and nearby lymph nodes
Approach Keyhole (VATS or robotic) or open
Operation time About 2-4 hours
Hospital stay Usually 2-5 days
Recovery About 4-8 weeks for most activities
Main side effects Pain, air leak, chest infection, irregular heartbeat, breathlessness

2. How it works

Removing the tumour and its drainage

During a lobectomy, the surgeon divides and seals the artery, veins and airway that supply the lobe, then removes the lobe as a single piece. Lymph nodes in the centre of the chest are removed or sampled so that the stage of the cancer can be confirmed.

Lung operations compared

Operation What is removed When used
Wedge resection A small wedge of lung around the tumour Very small tumours or people with limited lung function
Segmentectomy One or more segments, the subdivisions of a lobe Selected small tumours
Lobectomy A whole lobe Standard for most early lung cancers
Bilobectomy Two lobes on the right side Tumours crossing between lobes
Pneumonectomy A whole lung Central tumours that cannot be removed with a lobectomy

Keyhole or open surgery

Approach Features
VATS Two to four small cuts; camera guides the operation
Robotic Similar small cuts; the surgeon controls robotic arms from a console
Open (thoracotomy) A cut of around 15-20 cm between the ribs

Keyhole approaches usually mean less pain and a shorter hospital stay. Open surgery may be needed for large or central tumours, or if difficulties arise during a keyhole operation.

3. Who it is for

Conditions treated

Condition Role of lobectomy
Non-small cell lung cancer Standard operation for stage I-II and selected stage III cancer
Lung adenocarcinoma The most common type treated with lobectomy
Lung squamous cell carcinoma Often central, sometimes needing a sleeve lobectomy
Large cell lung carcinoma Surgery for early-stage disease
Typical pulmonary carcinoid Lobectomy or a smaller operation, depending on position
Atypical pulmonary carcinoid Lobectomy with lymph node removal
Small cell lung cancer Rarely, for very early disease, followed by chemotherapy

Who is suitable

Requirement Why
Cancer limited to the chest and removable Surgery aims for complete removal
Adequate lung function Enough breathing reserve after losing a lobe
Adequate heart function To cope with surgery and recovery
General fitness Lower risk of complications

Sleeve lobectomy

When a tumour sits at the point where the lobe’s airway joins the main airway, the surgeon may remove a ring (sleeve) of the main airway along with the lobe and then join the ends. This can avoid removing the whole lung.

4. Before treatment

Step Why it is done
CT scan of chest Shows the size and position of the tumour
PET-CT scan Looks for spread to lymph nodes or elsewhere
Lymph node sampling (EBUS or mediastinoscopy) Checks nodes in the centre of the chest
Brain scan For some larger tumours
Breathing tests Measure lung function and predict function after surgery
Exercise testing For borderline lung function
Heart checks ECG and sometimes an echocardiogram
Biopsy and gene testing Helps plan any treatment before or after surgery

Getting fit for surgery

Stopping smoking, walking daily, and doing breathing exercises before surgery can reduce complications. Many hospitals offer prehabilitation programmes. Even a few weeks of preparation can help.

Treatment before surgery

Some people with larger tumours or lymph node spread receive chemotherapy combined with immunotherapy before surgery. This can shrink the cancer and lower the chance of it coming back.

5. What to expect: step by step

Step What happens
1. Admission Usually on the day of surgery
2. Anaesthetic General anaesthetic; one lung is deflated so the surgeon can work
3. Surgery The lobe and lymph nodes are removed
4. Chest drain A tube drains air and fluid from the chest
5. Recovery room Close monitoring as you wake up
6. Ward Early walking and breathing exercises with a physiotherapist
7. Drain removal When the air leak stops and drainage is low
8. Home Usually 2-5 days after surgery

Pain relief

Good pain control is important so that you can breathe deeply and cough. Options include nerve blocks, epidurals, patient-controlled pain pumps and tablets. Let the team know if pain stops you breathing deeply.

6. Side effects and risks

Complication What to expect
Pain Common; usually improves over weeks, but some people have long-lasting nerve pain
Air leak Air escaping from the lung surface; may keep the drain in longer
Chest infection Prevented with breathing exercises and early walking
Irregular heartbeat Atrial fibrillation in some people; usually treated with medicines
Bleeding Uncommon; occasionally needs a return to theatre
Blood clots Prevented with injections and stockings
Breathlessness Usually improves as you recover
Fluid around the lung May need draining

Long-term breathing

Most people notice some reduction in breathing capacity after a lobectomy, especially with exertion. The amount depends on lung function before surgery and the lobe removed. In the LCSG trial, people who had a smaller limited resection did not have measurably better lung function later on than those who had a lobectomy (Ginsberg and Rubinstein, 1995). Pulmonary rehabilitation can improve fitness after surgery.

Older people

Age alone does not rule out a lobectomy. Many people in their seventies and eighties have successful operations. What matters more is overall fitness, heart and lung function and other health conditions. A careful assessment, sometimes including a frailty review, helps decide whether surgery, a smaller operation or radiotherapy is the best option.

7. Results and outlook

Study Main finding
Lung Cancer Study Group trial, 247 patients Limited resection was linked to a tripling of local recurrence compared with lobectomy, so lobectomy became the standard (Ginsberg and Rubinstein, 1995)
JCOG0802 trial, 1,106 patients with tumours up to 2 cm Five-year survival was 94.3% after segmentectomy and 91.1% after lobectomy (Saji et al., 2022)
CALGB 140503 trial, 697 patients with tumours up to 2 cm Sublobar resection matched lobectomy for disease-free survival; 5-year overall survival was about 80% and 79% (Altorki et al., 2023)

What the recent trials mean

For most early lung cancers, lobectomy remains the standard operation. For very small peripheral tumours of 2 cm or less, recent trials show that a smaller operation can give similar results while saving some lung tissue (Saji et al., 2022; Altorki et al., 2023). Your surgeon will consider the size and position of the tumour, the lymph node findings and your lung function when choosing the best operation.

Outlook

Survival after lobectomy depends mainly on the stage of the cancer. People with small tumours and no lymph node spread do best. Treatment after surgery can further reduce the chance of the cancer coming back for some people.

8. Recovery and aftercare

Tip Why
Walk every day, building up gradually Improves breathing and fitness
Keep doing breathing exercises Helps the lung re-expand
Support your chest when coughing Reduces pain
Avoid heavy lifting for about 4-6 weeks Allows healing
Do not smoke Protects the remaining lung
Report fever, increasing breathlessness or chest pain Could signal infection, clot or fluid

Wound and drain site care

Keep the wounds clean and dry for the first few days, then shower normally and pat them dry. The site where the chest drain was may leak a little fluid for a day or two and is usually closed with a stitch that a nurse removes later. Numbness or tingling around the scars is common and often improves over months.

Treatment after surgery

Depending on the stage and the features of the cancer, further treatment may be recommended. Chemotherapy, immunotherapy or targeted tablets may lower the risk of recurrence, especially when the tumour was larger or lymph nodes were involved.

Follow-up

Follow-up usually includes regular CT scans for at least 5 years. These look for recurrence and for new lung cancers, which are more common in people who have had one.

Coping with tiredness and mood

Feeling tired for several weeks after a lobectomy is normal, and many people also feel low or anxious while they recover and wait for results. Pacing your day, resting when you need to and accepting help can make a real difference. Talk to your specialist nurse if low mood persists.

Returning to normal

Most people return to driving after about 4 weeks, to desk work after 4-8 weeks and to more physical work later. Flying is usually possible a few weeks after the drain has been removed and the lung has fully re-expanded, but check with your team.

9. Alternatives

Alternative When it is considered
Stereotactic body radiotherapy (SBRT) Early cancer in people who cannot have or do not want surgery
Segmentectomy or wedge resection Very small peripheral tumours or limited lung function
Radiofrequency and microwave ablation Small tumours in people unfit for surgery or SBRT
EGFR inhibitors Given after surgery for EGFR-mutant cancer
ALK inhibitors Given after surgery for some ALK-positive cancer
Immune checkpoint inhibitors Before or after surgery for some stage II-III cancers

10. Frequently asked questions

Question Answer
Can I live normally with one lobe removed? Yes, most people return to everyday activities
Will I be breathless? Some people notice it with exertion; it often improves over months
Is keyhole surgery as good as open surgery? For suitable tumours, cancer results are similar, with a quicker recovery
How long will the scars take to heal? The skin heals in a couple of weeks; inner healing takes longer
When can I fly? Usually after a few weeks; ask your team
Will the lobe grow back? No, but the remaining lung expands to fill some of the space
Can I exercise afterwards? Yes; start with walking and build up, avoiding heavy upper body exercise for a few weeks
Will I need oxygen at home? Most people do not
Do I need chemotherapy too? It depends on the stage and type of cancer

11. Questions to ask your care team

  • Is a lobectomy or a smaller operation best for me?
  • Will the operation be keyhole or open?
  • What do my breathing tests mean for life after surgery?
  • Will I need treatment before or after surgery?
  • What are the main risks for me?
  • How long will recovery take, and when can I return to work?

Resources

  1. Altorki, N. et al. (2023) ‘Lobar or sublobar resection for peripheral stage IA non-small-cell lung cancer’, New England Journal of Medicine, 388(6), pp. 489-498.
  2. Ginsberg, R.J. and Rubinstein, L.V. (1995) ‘Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer’, Annals of Thoracic Surgery, 60(3), pp. 615-623.
  3. Saji, H. et al. (2022) ‘Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial’, The Lancet, 399(10335), pp. 1607-1617.
  4. National Cancer Institute (2026) Non-Small Cell Lung Cancer Treatment (PDQ) – Health Professional Version. Available at: https://www.cancer.gov/types/lung/hp/non-small-cell-lung-treatment-pdq (Accessed: October 2026).

Prepared by the editorial team, October 2026.